Cerebral embolism as a cause of stroke and transient ischemic attack

Echocardiography

Volumn 13, Issue 5, 1996, Pages 513-518

  Meyer, John Stirling ^a,b   Muramatsu, Kazuhiro ^a   Shirai, Toshitaka ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

cerebral embolism; cerebrovascular disease; emboli; etiology

Indexed keywords

ARTICLE; BRAIN EMBOLISM; BRAIN INFARCTION; COMPUTER ASSISTED TOMOGRAPHY; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; ECHOENCEPHALOGRAPHY; HEART ARRHYTHMIA; HOLTER MONITORING; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 0029834610     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8175.1996.tb00929.x     Document Type: Article

References (16)

1. Boughner DR, Barnett HJM: The enigma of the risk of stroke in mitral valve prolapse. Stroke 1983;14:175-177.
2. Meyer JS, Charney JZ, Rivera VM, et al: Cerebral embolization: Prospective clinical analysis of 42 cases. Stroke 1971;2:541-554.
3. Britton M, Gustavson C: Non-rheumatic atrial fibrillation as a risk factor for stroke. Stroke 1985;16:183-188.
4. Hanna JP, Sun JP, Furlan AJ, et al: Patent foramen ovale and brain infarct. Echocardiographic predictors, recurrence, and prevention. Stroke 1994;25:782-786.
5. Itoh T, Matsumoto M, Handa N, et al: Paradoxical embolism as a cause of ischemic stroke of uncertain etiology. Stroke 1994;25: 771-775.
6. Amarenco P, Cohen A, Taourio C, et al: Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994;331: 1474-1479.
7. Kistler JP: The risk of embolic stroke - Another piece of the puzzle. N Engl J Med 1994; 331:1517-1519.
8. Meyer JS, Obara K, Muramatsu K: Diaschisis. Neurol Res 1993;15:362-366.
9. Obara K, Meyer JS, Muramatsu K, et al: Cerebral density and perfusion measured among heart disease patients with and without stroke. Neurol Res 1995;17:377-383.
10. Meyer JS, Obara K, Muramatsu K, et al: Cognitive performance, dementia and their relationships to cardiac disease. In Hartman A, Hearse DJ, Kuschinsky W (eds): Cerebral Ischemia and the Heart. Springer-Verlag, Berlin, 1996; (In press).
11. The Canadian Cooperative Study Group: A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978; 299:53-59.
12. Antiplatelet Trialists' Collaboration: Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J 1988;296:320-321.
13. Hass WK, Easton JD, Adams HP Jr, et al, the Ticlopidine Aspirin Stroke Study Group: A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989;321: 501-507.
14. Gent M, Blakely JA, Easton JD, et al, the CATS Group: The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989;1:1215-1220.
15. Sage JI: Stroke. The use and overuse of heparin in therapeutic trials. Arch Neurol 1985;42: 315-317.
16. Harenberg J, Weuster B, Pfitzer M, et al: Prophylaxis of embolic events in patients with atrial fibrillation using low molecular weight heparin. Semin Thromb Hemost 1993;19(Suppl 1):116-121.